Intellectual Property Contracts & Agreements in the Biotechnology Industry

2,876 Contracts & Agreements

Browse by Subcategory

License Agreements (2,851 contracts from 515 companies)
Trademark Agreements (25 | 9)

Browse by Company

2seventy bio, Inc. (5 contracts)
4D Molecular Therapeutics Inc (5)
89bio, Inc. (1)
ABEONA THERAPEUTICS INC. (6)
ACADIA PHARMACEUTICALS INC (7)
ACCELERON PHARMA INC (2)
Accustem Sciences Inc. (1)
Achaogen, Inc. (6)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (25)
Actinium Pharmaceuticals, Inc. (4)
Acumen Pharmaceuticals, Inc. (1)
Adagio Therapeutics, Inc. (3)
Adamas Pharmaceuticals Inc (2)
Adhera Therapeutics, Inc. (15)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (2)
ADURO BIOTECH, INC. (16)
Advaxis, Inc. (5)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (8)
AGENUS INC (20)
AGIOS PHARMACEUTICALS INC (2)
AILERON THERAPEUTICS INC (6)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (2)
Akebia Therapeutics, Inc. (6)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (6)
Aldeyra Therapeutics, Inc. (3)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (4)
Alkermes plc. (10)
Allakos Inc. (6)
Allarity Therapeutics, Inc. (16)
Allena Pharmaceuticals, Inc. (2)
Alliqua BioMedical, Inc. (5)
Allogene Therapeutics, Inc. (1)
Allovir, Inc. (3)
ALNYLAM PHARMACEUTICALS, INC. (5)
Alpha Healthcare Acquisition Corp. (10)
ALPINE IMMUNE SCIENCES, INC. (6)
Altimmune, Inc. (9)
Alzamend Neuro, Inc. (6)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (4)
Amgen Inc. (2)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (2)
Amplitude Healthcare Acquisition Corp (1)
ANAPTYSBIO INC (2)
Anika Therapeutics (3)
Anixa Biosciences Inc (7)
Annovis Bio, Inc. (3)
Apellis Pharmaceuticals, Inc. (2)
APPLIED GENETIC TECHNOLOGIES CORP (12)
Applied Therapeutics Inc. (2)
Aptevo Therapeutics Inc. (5)
Aptose Biosciences Inc. (1)
AQUINOX PHARMACEUTICALS, INC (3)
Aravive, Inc. (6)
Arbutus Biopharma Corp (7)
ARCA biopharma, Inc. (10)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (7)
Arcutis Biotherapeutics, Inc. (3)
ARDELYX, INC. (9)
ARENA PHARMACEUTICALS INC (3)
Aridis Pharmaceuticals, Inc. (5)
ARROWHEAD PHARMACEUTICALS, INC. (8)
Arsanis, Inc. (11)
Artiva Biotherapeutics, Inc. (7)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (4)
Atara Biotherapeutics, Inc. (14)
Athenex, Inc. (37)
ATHERSYS, INC (6)
ATOSSA GENETICS INC (7)
Atreca, Inc. (2)
Aura Biosciences, Inc. (3)
AVEO PHARMACEUTICALS INC (10)
Avid Bioservices, Inc. (6)
AVROBIO, Inc. (9)
Axovant Sciences Ltd. (4)
Ayala Pharmaceuticals, Inc. (3)
AZIYO BIOLOGICS, INC. (2)
AzurRx BioPharma, Inc. (3)
Beam Therapeutics Inc. (8)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (9)
BICYCLE THERAPEUTICS Ltd (1)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (4)
BioCardia, Inc. (1)
BIOCRYST PHARMACEUTICALS INC (4)
Biohaven Pharmaceutical Holding Co Ltd. (8)
BioLife4D Corp (4)
BIOMARIN PHARMACEUTICAL INC (8)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (7)
Biostage, Inc. (3)
BIOTIME INC (19)
BioXcel Therapeutics, Inc. (1)
BIOXYTRAN, INC (4)
Blue Water Vaccines Inc. (9)
bluebird bio, Inc. (20)
Blueprint Medicines Corp (1)
Bone Biologics Corp (7)
BRAINSTORM CELL THERAPEUTICS INC. (1)
BriaCell Therapeutics Corp. (1)
BridgeBio Pharma, Inc. (7)
BullFrog AI Holdings, Inc. (10)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (3)
Cabaletta Bio, Inc. (5)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (1)
Calyxt, Inc. (3)
Candel Therapeutics, Inc. (6)
CAPRICOR THERAPEUTICS, INC. (13)
Capstone Therapeutics Corp. (6)
CareDx, Inc. (2)
Caribou Biosciences, Inc. (8)
CASI Pharmaceuticals, Inc. (7)
CASTLE BIOSCIENCES INC (1)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (30)
CATALYST PHARMACEUTICALS, INC. (10)
Celcuity Inc. (2)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (7)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Centessa Pharmaceuticals Ltd (4)
Century Therapeutics, Inc. (11)
CEREBAIN BIOTECH CORP. (1)
Chanticleer Holdings, Inc. (3)
Chardan Healthcare Acquisition 2 Corp. (1)
Chardan Healthcare Acquisition Corp. (8)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (5)
CHIMERIX INC (4)
Cidara Therapeutics, Inc. (1)
CLEVELAND BIOLABS INC (4)
CM Life Sciences III Inc. (2)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (11)
Conatus Pharmaceuticals Inc. (6)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (1)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (3)
Cortexyme, Inc. (4)
Corvus Pharmaceuticals, Inc. (3)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
Crinetics Pharmaceuticals, Inc. (1)
CTI BIOPHARMA CORP (4)
Cue Biopharma, Inc. (15)
Cullinan Oncology, LLC (3)
Curative Biotechnology Inc (17)
CURIS INC (2)
Cyclacel Pharmaceuticals, Inc. (7)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (2)
Cytokinetics, Incorporated (1)
CytomX Therapeutics, Inc. (5)
CYTORI THERAPEUTICS, INC. (6)
CYTRX CORP (2)
Day One Biopharmaceuticals Holding Co LLC (4)
Decibel Therapeutics, Inc. (8)
Deciphera Pharmaceuticals, Inc. (1)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (10)
Dermira, Inc. (3)
Design Therapeutics, Inc. (1)
Dicerna Pharmaceuticals Inc (4)
Diffusion Pharmaceuticals Inc. (4)
Digital Development Partners, Inc. (1)
DYADIC INTERNATIONAL INC (3)
Dynamics Special Purpose Corp. (4)
DYNAVAX TECHNOLOGIES CORP (1)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (11)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (8)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (13)
Elevation Oncology, Inc. (2)
Emerald Bioscience, Inc. (10)
Emergent BioSolutions Inc. (1)
Enanta Pharmaceuticals, Inc. (1)
Enochian Biosciences Inc (2)
Entrada Therapeutics, Inc. (3)
ENZOLYTICS INC (1)
Epizyme, Inc. (2)
Erasca, Inc. (5)
Esperion Therapeutics, Inc. (1)
ESSA Pharma Inc. (1)
Evelo Biosciences, Inc. (6)
EXACT SCIENCES CORP (15)
Exelixis (5)
EXICURE, INC. (13)
FATE THERAPEUTICS INC (18)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (10)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (12)
Flex Pharma, Inc. (7)
Flexion Therapeutics Inc (2)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (3)
FS Development Corp. (5)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (3)
Gene Biotherapeutics, Inc. (11)
GENELUX CORP (4)
Generation Bio Co. (4)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (11)
GeoVax Labs, Inc. (5)
GERON CORP (6)
Gilead Sciences (11)
Global Blood Therapeutics, Inc. (2)
GLYCOMIMETICS INC (2)
GOLDENWELL BIOTECH, INC. (2)
Gossamer Bio, Inc. (3)
Grail, Inc. (5)
Graphite Bio, Inc. (7)
Greater Cannabis Company, Inc. (1)
Greenwich LifeSciences, Inc. (3)
Gritstone Oncology, Inc. (5)
GT Biopharma, Inc. (17)
GTX INC (23)
HARBOR DIVERSIFIED, INC. (4)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
Health Sciences Acquisitions Corp (2)
HEAT BIOLOGICS, INC. (32)
HedgePath Pharmaceuticals, Inc. (5)
HilleVax, Inc. (1)
Hillstream BioPharma Inc. (2)
HISTOGENICS CORP (17)
Homology Medicines, Inc. (13)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (1)
iBio, Inc. (5)
Icosavax, Inc. (8)
IDEAYA Biosciences, Inc. (4)
IDERA PHARMACEUTICALS, INC. (5)
Immix Biopharma, Inc. (2)
IMMUCELL CORP (2)
IMMUNE PHARMACEUTICALS INC (7)
Immune Therapeutics, Inc. (8)
ImmunoCellular Therapeutics, Ltd. (11)
IMMUNOGEN INC (14)
Immunome Inc. (5)
IMMUNOMEDICS INC (3)
IN8BIO, INC. (8)
Incyte (4)
INFINITY PHARMACEUTICALS, INC. (5)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (7)
Inmune Bio, Inc. (9)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (3)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Intellia Therapeutics, Inc. (12)
INTERCEPT PHARMACEUTICALS, INC. (10)
International Stem Cell CORP (9)
INTREXON CORP (1)
Intrinsic Medicine, Inc. (7)
IONIS PHARMACEUTICALS INC (22)
IOVANCE BIOTHERAPEUTICS, INC. (3)
IRONWOOD PHARMACEUTICALS INC (9)
Isoray, Inc. (12)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (2)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (1)
Karuna Therapeutics, Inc. (3)
Karyopharm Therapeutics Inc. (4)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kiniksa Pharmaceuticals, Ltd. (4)
Kiromic Biopharma, Inc. (4)
Kura Oncology, Inc. (9)
LA JOLLA PHARMACEUTICAL CO (2)
Lantern Pharma Inc. (6)
LEAP THERAPEUTICS, INC. (3)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (19)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (23)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (5)
LONGEVERON LLC (5)
Lyell Immunopharma, Inc. (1)
MACROGENICS INC (4)
MADRIGAL PHARMACEUTICALS, INC. (2)
Magenta Therapeutics, Inc. (6)
MAIA Biotechnology, Inc. (6)
MANHATTAN SCIENTIFICS INC (1)
Marker Therapeutics, Inc. (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (1)
MEDICINOVA INC (8)
MEI Pharma, Inc. (6)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (1)
Mersana Therapeutics, Inc. (7)
Merus N.V. (1)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (11)
MiMedx Group, Inc. (13)
Minerva Neurosciences, Inc. (8)
MiNK Therapeutics, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (13)
Mirum Pharmaceuticals, Inc. (7)
Molecular Templates, Inc. (6)
Moleculin Biotech, Inc. (13)
Momenta Pharmaceuticals, Inc. (2)
Monopar Therapeutics (10)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (2)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (2)
NANOVIRICIDES, INC. (4)
NantKwest, Inc. (12)
Natera, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (5)
NEUROBIOLOGICAL TECHNOLOGIES INC (5)
NEUROCRINE BIOSCIENCES INC (2)
NEUROTROPE BIOSCIENCE, INC. (3)
Neurotrope, Inc. (1)
NEWLINK GENETICS CORP (45)
NexImmune, Inc. (1)
NextCure, Inc. (2)
Nkarta, Inc. (1)
NOVAVAX INC (8)
Novus Therapeutics, Inc. (3)
NTN BUZZTIME INC (6)
Nuo Therapeutics, Inc. (7)
Nuvectis Pharma, Inc. (4)
Ohr Pharmaceutical Inc (2)
Omega Therapeutics, Inc. (5)
OncoCyte Corp (4)
Oncorus, Inc. (7)
ONCOSEC MEDICAL Inc (1)
Ophthotech Corp. (7)
Opko Health, Inc. (12)
ORAGENICS INC (10)
Orchard Therapeutics plc (1)
Organogenesis Holdings Inc. (1)
ORGANOVO HOLDINGS, INC. (5)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (3)
Ovid Therapeutics Inc. (4)
Oyster Point Pharma, Inc. (1)
PALATIN TECHNOLOGIES INC (2)
PepGen Inc. (2)
Pfenex Inc. (13)
PharmaCyte Biotech, Inc. (3)
PhaseBio Pharmaceuticals Inc (7)
PIERIS PHARMACEUTICALS, INC. (7)
PLURISTEM THERAPEUTICS INC (2)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (10)
Praxis Precision Medicines, Inc. (2)
PRECISION BIOSCIENCES INC (9)
Prelude Therapeutics Inc (2)
PREMIER BIOMEDICAL INC (6)
Prevail Therapeutics Inc. (2)
Principia Biopharma Inc. (5)
Progenics Pharmaceuticals, Inc. (9)
Prometheus Biosciences, Inc. (5)
Protagenic Therapeutics, Inc. (3)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (7)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (13)
PTC THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (14)
Pyxis Oncology, Inc. (7)
Q BioMed Inc. (3)
Qrons Inc. (5)
Radius Health, Inc. (5)
Rallybio Corp (4)
RECURSION PHARMACEUTICALS, INC. (3)
Regeneron Pharmaceuticals (11)
REGENERX BIOPHARMACEUTICALS INC (3)
REGENXBIO Inc. (33)
Regulus Therapeutics Inc. (1)
Reneo Pharmaceuticals, Inc. (1)
Repare Therapeutics Inc. (1)
Retrophin, Inc. (15)
REXAHN PHARMACEUTICALS, INC. (5)
Rezolute, Inc. (6)
RHYTHM PHARMACEUTICALS, INC. (6)
RIGEL PHARMACEUTICALS INC (3)
RITTER PHARMACEUTICALS INC (13)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (6)
Sana Biotechnology, Inc. (36)
SANGAMO THERAPEUTICS, INC (14)
Sarepta Therapeutics, Inc. (7)
Savara Inc (5)
SEATTLE GENETICS INC (9)
SELECTA BIOSCIENCES INC (9)
SELLAS Life Sciences Group, Inc. (37)
Sensei Biotherapeutics, Inc. (1)
Seres Therapeutics, Inc. (2)
Sesen Bio, Inc. (6)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sierra Oncology, Inc. (5)
Sigilon Therapeutics, Inc. (7)
Silverback Therapeutics, Inc. (4)
Social Capital Suvretta Holdings Corp. III (1)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (18)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (4)
Sorrento Therapeutics, Inc. (13)
Spectrum Pharmaceuticals, Inc. (11)
Spero Therapeutics, Inc. (10)
SPHERIX INC (5)
Spring Bank Pharmaceuticals, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (2)
Stellar Biotechnologies, Inc. (9)
Stoke Therapeutics, Inc. (4)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (5)
Sunshine Biopharma, Inc (2)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (4)
Syndax Pharmaceuticals Inc (15)
SYNLOGIC, INC. (16)
Synthetic Biologics, Inc. (10)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (1)
Talaris Therapeutics, Inc. (3)
Taysha Gene Therapies, Inc. (3)
TENAX THERAPEUTICS, INC. (9)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (4)
Therapeutics Acquisition Corp. (2)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (6)
Tracon Pharmaceuticals, Inc. (8)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (2)
TREVENA INC (1)
Trovagene, Inc. (2)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (3)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (18)
Unicycive Therapeutics, Inc. (3)
uniQure N.V. (5)
United Therapeutics Corp (4)
Unity Biotechnology, Inc. (29)
Unum Therapeutics Inc. (1)
UroGen Pharma Ltd. (2)
VACCINEX, INC. (2)
Vaccitech plc (4)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (1)
Vaxcyte, Inc. (2)
Vaxxinity, Inc. (1)
VBI Vaccines Inc (1)
Vera Therapeutics, Inc. (4)
Verastem, Inc. (3)
Vericel Corp (6)
Vertex Pharmaceuticals Inc (2)
Verve Therapeutics, Inc. (3)
VICAL INC (20)
Vicapsys Life Sciences, Inc. (2)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (3)
Vir Biotechnology, Inc. (14)
Virios Therapeutics, LLC (1)
VistaGen Therapeutics, Inc. (8)
VITAL THERAPIES INC (1)
Vor Biopharma Inc. (4)
Voyager Therapeutics, Inc. (5)
vTv Therapeutics Inc. (10)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (1)
Xencor Inc (8)
Xenetic Biosciences, Inc. (7)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (2)
XOMA Corp (18)
Y-mAbs Therapeutics, Inc. (4)
YIELD10 BIOSCIENCE, INC. (1)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (8)
Zai Lab Ltd (5)
Zentalis Pharmaceuticals, LLC (4)
ZIOPHARM ONCOLOGY INC (9)

Recent Contracts

License, Development and Commercialization Agreement, by and between the Company and Lees Pharmaceutical (HK) Ltd., dated January 12, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Amendment No. 1, effective as of January 17, 2024, to the License Agreement, between Windtree and Philip Morris Products S.A. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Amendment No. 1, effective as of January 17, 2024, to the Amended and Restated License Agreement, between Windtree and Philip Morris USA Inc. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Second Amendment to the Exclusive License Agreement by and between the Registrant and The Washington University, dated as of November 28, 2023 (HISTOGENICS CORP, Filed With SEC on April 16, 2024)
License Agreement, dated March 27, 2023, between Proteomedix and Laboratory Corporation of America Holdings (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
License Modification 1, dated August 31, 2022, to Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research, dated August 24, 2021 (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
First Amendment, dated January 10, 2019, to Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy, dated March 16, 2017 (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Second Amendment to Exclusive License Agreement, dated November 3, 2022, by and between Genprex, Inc. and the University of Pittsburgh - Of the Commonwealth System of Higher... (Genprex, Inc., Filed With SEC on April 1, 2024)
License Agreement, by and between Perspective Therapeutics, Inc. and Mayo Foundation for Medical Education and Research, dated December 31, 2023 (Isoray, Inc., Filed With SEC on March 28, 2024)
Letter Agreement re License Agreement between Flagship Pioneering Innovations V, Inc. and the Registrant dated December 31, 2023 relating to the License Agreement dated March 12,... (Omega Therapeutics, Inc., Filed With SEC on March 28, 2024)
Amendment No. 2 to the Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated March 13, 2024 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Second Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated January 13, 2024 (Cue Biopharma, Inc., Filed With SEC on March 28, 2024)
License Agreement, by and between the registrant and Zentalis Pharmaceuticals, Inc., dated January 5, 2024 (Immunome Inc., Filed With SEC on March 28, 2024)
License Agreement by and among TG Therapeutics, Inc., TG Cell Therapy, Inc. and Precision BioSciences, Inc (PRECISION BIOSCIENCES INC, Filed With SEC on March 27, 2024)
License Agreement dated November 29, 2017, by and between Immunome, Inc. (as assignee) and Bristol-Myers Squibb Company, as amended (Immunome Inc., Filed With SEC on March 26, 2024)
License and Supply Agreement, dated March 15, 2024, between Fennec Pharmaceuticals, Inc. and Norgine Pharma UK Limited (FENNEC PHARMACEUTICALS INC., Filed With SEC on March 21, 2024)
Letter Agreement, dated December 20, 2023, between Alpine Immune Sciences Inc. and AbbVie Global Enterprises Ltd. amending the Option and License Agreement, dated June 17, 20 (ALPINE IMMUNE SCIENCES, INC., Filed With SEC on March 20, 2024)
Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Coherus BioSciences, Inc., Filed With SEC on March 15, 2024)
License Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 22, 2023 (Century Therapeutics, Inc., Filed With SEC on March 14, 2024)
License and Supply Agreement, dated as of January 16, 2024, by and between UroGen Pharma Ltd. and Medac Gesellschaft fr klinische Spezialprparate m.b.H (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
License Agreement, dated as of August 3, 2017, by and between Solid Biosciences, LLC and President and Fellows of Harvard College (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
License Agreement, dated as of June 23, 2016, by and between Solid GT, LLC and President and Fellows of Harvard College (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
Life Technologies Cell Line License Agreement, dated as of November 20, 2016, by and between Solid Biosciences, LLC and Life Technologies Corporation (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
Patent License Agreement, dated as of March 10, 2016, by and between Solid GT, LLC and the Regents of the University of Michigan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
License Agreement, dated as of October 15, 2015, by and between Solid GT, LLC and The Curators of the University of Missouri (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
Exclusive Patent License Agreement, dated as of October 16, 2015, by and between Solid GT, LLC and the University of Washington (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
Amendment 2 to Exclusive License Agreement, dated December 20, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
Amendment 1 to Exclusive License Agreement, dated July 4, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
Exclusive License Agreement, by and between the Registrant and (Entrada Therapeutics, Inc., Filed With SEC on March 13, 2024)
Second Amendment to License Agreement, dated January 16, 2024, by and between 2seventy bio, Inc. and the National Institutes of Health (2seventy bio, Inc., Filed With SEC on March 7, 2024)
Amendment No. 1 to the License Agreement for RAF, dated March 4, 2024, by and between Day One Biopharmaceuticals, Inc. and Sunesis Pharmaceuticals, Inc (Day One Biopharmaceuticals Holding Co LLC, Filed With SEC on March 7, 2024)
License Agreement for Space and Services, dated February 8, 2024, by and between Soleno Therapeutics, Inc. and Hudson Towers at Shore Center, LLC (SOLENO THERAPEUTICS INC, Filed With SEC on March 7, 2024)
License and Development Agreement, dated January 8, 2023, by and between Selecta Biosciences, Inc. and Audentes Therapeutics, Inc (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Patent License Agreement by and between Biogen MA, Inc. and Cartesian Therapeutics, Inc., dated September 8, 2023 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Patent License Agreement, between Cartesian Therapeutics, Inc. and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute of the... (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Amendment No. 1 to License and Development Agreement, dated as of October 31, 2023, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
Second Amendment to the UTRF License Agreement dated March 4, 2024 (GTX INC, Filed With SEC on March 7, 2024)
Amendment No. 1 to License Agreement for RAF, dated March 4, 2024, by and between the Registrant and Day One Biopharmaceuticals, Inc (SUNESIS PHARMACEUTICALS INC, Filed With SEC on March 7, 2024)